Search Result

No of hits: 261

    Institut für Psychologie, Abteilung für Biologische und Differentielle Psychologie

  1. Detailinformationen: Emotional reactions to standardized stimuli in women with borderline personality disorder: stronger negative affect, but no differences in reactivityJ Nerv Ment Dis Jacob, G. A., Hellstern, K., Ower, N., Pillmann, M., Scheel, C. N., Rusch, N., Lieb, K.: Emotional reactions to standardized stimuli in women with borderline personality disorder: stronger negative affect, but no differences in reactivity J Nerv Ment Dis, 2009; 197 (11): 808-15. : http://www.ncbi.nlm.nih.gov/pubmed/19996718

    Universitätsklinik für Psychiatrie und Psychosomatik, Abteilung für Psychiatrie und Psychotherapie

  1. Detailinformationen: Biologisch-psychiatrische Forschung. Lieb K., Riemann D., Berger M.: Biologisch-psychiatrische Forschung. In: Gustav Fischer, Stuttgart, 1994.
  2. Detailinformationen: Cyclooxygenase-2 expression in rat microglia is induced by adenosine a(2a)-receptors. Fiebich B L, Biber K, Lieb K, Calker D v, Berger M, Bauer J, Gebicke-Härter PJ: Cyclooxygenase-2 expression in rat microglia is induced by adenosine a(2a)-receptors. Glia, 1996; 18: 152-160.
  3. Detailinformationen: Das chronische Müdigkeitssyndrom ("chronic fatigue syndrome", CFS). Lieb K, Dammann G, Berger M, Bauer J: Das chronische Müdigkeitssyndrom ("chronic fatigue syndrome", CFS). Nervenarzt, 1996; 67: 711-720.
  4. Detailinformationen: Demenzerkrankungen - Diagnose, Differentialdiagnose und Therapie. Rösler N, Hüll M, Lieb K, Wolf R, Berger M, Bauer J: Demenzerkrankungen - Diagnose, Differentialdiagnose und Therapie. Fortschr Med, 1996; 114: 351-356.
  5. Detailinformationen: Effects of NSAIDs on IL-1ß -induced IL-6 mRNA and protein synthesis in human astrocytoma cells. Fiebich BL, Lieb K, Hüll M, Berger M, Bauer J: Effects of NSAIDs on IL-1ß -induced IL-6 mRNA and protein synthesis in human astrocytoma cells. Neuroreport, 1996; 7: 1209-1213.
  6. Detailinformationen: Effects of substance P and selected other neuropeptides on the synthesis of interleukin-1? and interleukin-6 in human monocytes: a reexamination. Lieb K, Fiebich B L, Busse-Grawitz M, Hüll M, Berger M, Bauer J: Effects of substance P and selected other neuropeptides on the synthesis of interleukin-1? and interleukin-6 in human monocytes: a reexamination. J. Neuroimmunol., 1996; 67: 77-81.
  7. Detailinformationen: Interleukin-1? uses common and distinct signaling pathways for induction of the interleukin-6 and tumor necrosis factor ? genes in the human astrocytoma cell line U373. Lieb K, Kaltschmidt C, Kaltschmidt K, et al.: Interleukin-1? uses common and distinct signaling pathways for induction of the interleukin-6 and tumor necrosis factor ? genes in the human astrocytoma cell line U373. J Neurochem, 1996; 66: 1496-1503.
  8. Detailinformationen: Interleukin-1ß and tumor necrosis factor- induce expression of 1-antichymotrypsin in human astrocytoma cells by activation of nuclear factor-kappa. Lieb K, Fiebich B L, Schaller H, Berger M, Bauer J: Interleukin-1ß and tumor necrosis factor- induce expression of 1-antichymotrypsin in human astrocytoma cells by activation of nuclear factor-kappa. J Neurochem, 1996; 67: 2039-2044.
  9. Detailinformationen: Interleukin-1ß uses common and distinct signaling pathways for induction of the interleukin-6 and tumor necrosis factor genes in the human astrocytoma cell line U373. Lieb K, Kaltschmidt C, Kaltschmidt K, Bäuerle PA, Berger M, Bauer J, Fiebich BL: Interleukin-1ß uses common and distinct signaling pathways for induction of the interleukin-6 and tumor necrosis factor genes in the human astrocytoma cell line U373. J Neurochem, 1996; 66: 1496-1503.
  10. Detailinformationen: Interleukin-6 associated inflammatory processes in Alzheimer's disease: new therapeutic options. Hüll M, Fiebich B L, Lieb K, Strauss S, Berger M, Volk B, et al.: Interleukin-6 associated inflammatory processes in Alzheimer's disease: new therapeutic options. Neurobiol Aging, 1996; 17: 795-800.
  11. Detailinformationen: Kurzlehrbuch Biologie. Lieb K: Kurzlehrbuch Biologie.Mediscript Verlag, 4. Auflage. Auflage, 1996.
  12. Detailinformationen: Kurzlehrbuch Psychiatrie. Brunnhuber S, Lieb K: Kurzlehrbuch Psychiatrie.Mediscript Verlag, 3. Auflage. Auflage, 1996.
  13. Detailinformationen: Microglia as a model of NSAID action in the brain. Fiebich B L, Lieb K, Pairet M, et al.: Microglia as a model of NSAID action in the brain. Eur. J. Clin. Pharmacol., 1996; 50: 541.
  14. Detailinformationen: Neurobiologische Korrelate der Alzheimer-Krankheit.Spinale und zerebrale Prozesse. Rösler N, Hüll M, Lieb K, Bauer J: Neurobiologische Korrelate der Alzheimer-Krankheit. In: Spinale und zerebrale Prozesse. Einhorn-Presse-Verlag, 1996; 285-291.
  15. Detailinformationen: Pre- and postnatal development of dopaminergic neuron numbers in the male and female mouse midbrain. Lieb K, Andersen C, Lazarov N, Zienecker R, Urban I, Pilgrim C, Reisert I: Pre- and postnatal development of dopaminergic neuron numbers in the male and female mouse midbrain. Brain Res Dev Brain Res, 1996; 94: 37-43.
  16. Detailinformationen: Preattentive information processing as measured by backward masking and texton detection tasks in adolescents at high genetic risk for schizophrenia. Lieb K, Denz E, Hess R, Schüttler R, Kornhuber HH, Schreiber H: Preattentive information processing as measured by backward masking and texton detection tasks in adolescents at high genetic risk for schizophrenia. Schizophr. Res., 1996; 21: 171-182.
  17. Detailinformationen: Sex differentiation of rat hippocampal GABAergic neurons. Reisert I, Lieb K, Beyer C, Pilgrim C: Sex differentiation of rat hippocampal GABAergic neurons. Eur J Neurosci, 1996; 8: 1718-1724.
  18. Detailinformationen: Sex-specific vulnerability of developing dopaminergic neurons. Pilgrim C, Lieb K, Reisert I: Sex-specific vulnerability of developing dopaminergic neurons. In: Tectum Verlag, 1996; 100-103.
  19. Detailinformationen: Depression, borna disease, and amantadine. Lieb K, Hufert F, Bechter K, Bauer J, Kornhuber J: Depression, borna disease, and amantadine. Lancet, 1997; 349: 958.
  20. Detailinformationen: Die Beteiligung eines Interleukin-6-assoziierten Prozesses an der Pathogenese der Alzheimer-Demenz.Alzheimer-Krankheit. Hüll M, Rösler N, Lieb K, Fiebich B L, Berger M, Bauer J: Die Beteiligung eines Interleukin-6-assoziierten Prozesses an der Pathogenese der Alzheimer-Demenz. In: Rösler M, Retz W, Thome J (Hrsg.): Alzheimer-Krankheit. Beltz Deutscher Studien Verlag, 1997; 160-163.
  21. Detailinformationen: Expression and regulation of cyclooxygenase-2 in rat microglia. Bauer M K A, Lieb K, Schulze-Osthoff K, Berger M, Gebicke-Härter PC, Bauer J, Fiebich BL: Expression and regulation of cyclooxygenase-2 in rat microglia. Eur. J. Biochem., 1997; 243: 726-731.
  22. Detailinformationen: Immunologische Systemerkrankungen als Differentialdiagnose in der Psychiatrie. Lieb K, Vaith P, Berger M, Bauer J: Immunologische Systemerkrankungen als Differentialdiagnose in der Psychiatrie. Nervenarzt, 1997; 68: 696-707.
  23. Detailinformationen: No borna disease virus-specific RNA detected in blood from psychiatric patients in different regions of Germany. Lieb K, Hallensleben W, Czygan M, Stitz L, Staeheli P: No borna disease virus-specific RNA detected in blood from psychiatric patients in different regions of Germany. Lancet, 1997; 350: 1002.
  24. Detailinformationen: Potent inhibition of interleukin-6 expression in human astrocytoma cell line by tenidap. Lieb K, Fiebich B L, Hüll M, Berger M, Bauer J: Potent inhibition of interleukin-6 expression in human astrocytoma cell line by tenidap. Cell Tissue Res., 1997; 288: 251-257.
  25. Detailinformationen: Prostaglandin E2 induces interleukin-6 synthesis in human astrocytoma cells. Fiebich B L, Hüll M, Lieb K, Gyufko K, Berger M, Bauer J: Prostaglandin E2 induces interleukin-6 synthesis in human astrocytoma cells. J Neurochem, 1997; 68: 704-709.
  26. Detailinformationen: The neuropeptide P activates transcription factor NF-kB and kB-dependent gene expression in human astrocytoma cells. Lieb K, Fiebich B L, Berger M, Bauer J, Schulze-Osthoff K: The neuropeptide P activates transcription factor NF-kB and kB-dependent gene expression in human astrocytoma cells. J. Immunol., 1997; 159: 4952-4958.
  27. Detailinformationen: Borna disease virus as a cause of human neuropsychiatric disorders: fact or artefact? Lieb K, Czygan M, Bauer J, Berger M, Hallensleben W, Staeheli P: Borna disease virus as a cause of human neuropsychiatric disorders: fact or artefact? Eur Arch Psychiatry Clin Neurosci, 1998; 248: 146.
  28. Detailinformationen: Borna Disease Virus - Depression durch Infektion? Lieb K, Sauder C, Czygan M, Hallensleben W, Staeheli P: Borna Disease Virus - Depression durch Infektion? Via medici, 1998; 5: 52-53.
  29. Detailinformationen: Borna Disease Virus und psychiatrische Erkrankungen - Fakt oder Artefakt? Lieb K, Sauder C, Czygan M, Hallensleben W, Staeheli P: Borna Disease Virus und psychiatrische Erkrankungen - Fakt oder Artefakt? Deutsche Medizinische Wochenschrift, 1998; 123: 1217-1218.
  30. Detailinformationen: Bornaviren - Ursache psychiatrischer Erkrankungen? Zum aktuellen Stand der Diskussion. Lieb K, Staeheli P: Bornaviren - Ursache psychiatrischer Erkrankungen? Zum aktuellen Stand der Diskussion. Ars medici, 1998; 17: 1077-1079.
  31. Detailinformationen: Inflammatory mechanisms in Alzheimer's disease: Links between cytokine pathology and arachidonic acid metabolism. Bauer J, Hüll M, Lieb K, Fiebich BL: Inflammatory mechanisms in Alzheimer's disease: Links between cytokine pathology and arachidonic acid metabolism. Eur Arch Psychiatry Clin Neurosci, 1998; 248: S24.
  32. Detailinformationen: Interferon-alpha/beta induced changes in cerebral glucose metabolism as measured by positron emission tomography. Lieb K, Jüngling F, Brandt C, Lücking CH, Berger M, Bauer J: Interferon-alpha/beta induced changes in cerebral glucose metabolism as measured by positron emission tomography. Eur Arch Psychiatry Clin Neurosci, 1998; 248: 135.
  33. Detailinformationen: Mikroglia: Mechanismen der Aktivierung und Bedeutung bei der Pathogenese neuropsychiatrischer Erkrankungen. Gebicke-Härter PJ, Lieb K, Illes P, Berger M: Mikroglia: Mechanismen der Aktivierung und Bedeutung bei der Pathogenese neuropsychiatrischer Erkrankungen. Nervenarzt, 1998; 69: 752-762.
  34. Detailinformationen: Potential link between interleukin-6 and arachidonic acid metabolism in Alzheimer`s disease. Fiebich BL, Hüll M, Lieb K, Schumann G, Berger M, Bauer J: Potential link between interleukin-6 and arachidonic acid metabolism in Alzheimer`s disease. J Neural Transm, 1998; 53: 269-278.
  35. Detailinformationen: Regulation and inhibition of cytokine synthesis in astrocytes: Basci steps for the identification of new antiinflammatory drugs for the treatment of Alzheimer's disease. Lieb K, fiebich BL, Hüll M, Schumann G, Berger M, Bauer J: Regulation and inhibition of cytokine synthesis in astrocytes: Basci steps for the identification of new antiinflammatory drugs for the treatment of Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci, 1998; 248: 101.
  36. Detailinformationen: Substance P and histamine induce interleukin-6 expression in human astrocytoma cells by a mechanism involving protein kinase C and Nuclear Factor-IL-6. Lieb K, Schaller H, Bauer J, Berger M, Schulze-Osthoff K, Fiebich BL: Substance P and histamine induce interleukin-6 expression in human astrocytoma cells by a mechanism involving protein kinase C and Nuclear Factor-IL-6. J Neurochem, 1998; 70: 1577-1583.
  37. Detailinformationen: Antibacterial activity of hyperforin from St. John's wort. Fiebich BL, Heinrich M, Langosch JM, Kammerer N, Lieb K: Antibacterial activity of hyperforin from St. John's wort. The Lancet, 1999; 354: 777.
  38. Detailinformationen: Anti-inflammatory substances - a new therapeutic option in Alzheimer's disease. Hüll M, Fiebich BL, Schumann G, Lieb K, Bauer J: Anti-inflammatory substances - a new therapeutic option in Alzheimer's disease. Drug Discovery Today, 1999; 4: 275-282.
  39. Detailinformationen: Borna disease virus in human brains with a rare from of hippocampal degeneration but not in brains of patients with common neuropsychiatric disorders. Czygan M, Hallensleben W, Hofer M, Pollak S, Sauder C, Blizer T, Blümcke I, Riederer P, Bogerts B, Falkai P, Schwarz MJ, Masliah E, Staeheli P, Hufert FT, Lieb K: Borna disease virus in human brains with a rare from of hippocampal degeneration but not in brains of patients with common neuropsychiatric disorders. J Infect Dis, 1999; 180: 1695-1699.
  40. Detailinformationen: Borna-Disease-Virus - Ursache psychiatrischer Erkrankungen? Lieb K: Borna-Disease-Virus - Ursache psychiatrischer Erkrankungen? Deutsches Ärzteblatt, 1999; 96: 1422-1423.
  41. Detailinformationen: Bornaviren und psychiatrische Erkrankungen: Zusammenhänge weiterhin unklar. Staeheli P, Lieb K: Bornaviren und psychiatrische Erkrankungen: Zusammenhänge weiterhin unklar. Mitteilungsblatt des Instituts für Medizinische Mikrobiologie und Immunologie, 1999; 3: 2.
  42. Detailinformationen: Detection of interleukin-6 in the brains of Alzheimer's disease patients. Hüll M, Lieb K, Fiebich BL: Detection of interleukin-6 in the brains of Alzheimer's disease patients. Curr. Opin. Psychiatry, 1999; 12: S02-S01.
  43. Detailinformationen: Impairment in preattentive visual processing patients with Parkinson's disease. Lieb K, Brucker S, Bach M, Els T, Lücking CH, Greenlee ME: Impairment in preattentive visual processing patients with Parkinson's disease. Brain, 1999; 122: 303-313.
  44. Detailinformationen: Insomnia for 5 years. Lieb K, Maiwald M, Berger M, Voderholzer U: Insomnia for 5 years. The Lancet, 1999; 354: 1966.
  45. Detailinformationen: NK-1-receptor antagonism as a new antidepressant strategy - molecular analysis of NK-1-receptor regulation in the CNS. Lieb K, Czygan M, Fiebich BL, Berger M: NK-1-receptor antagonism as a new antidepressant strategy - molecular analysis of NK-1-receptor regulation in the CNS. Pharmacopsychiat., 1999; 32: 195.
  46. Detailinformationen: Potential link between Interleukin-6 and arachnidonic metabolism in Alzheimer's disease.Alzheimer's disease - from basic research to clinical application. Fiebich BL, Hüll M, Lieb K, Schumann G, Berger M, Bauer J: Potential link between Interleukin-6 and arachnidonic metabolism in Alzheimer's disease. In: Gertz HJ, Arendt T (Hrsg.): Alzheimer's disease - from basic research to clinical application. Springer Verlag, 1999; 269-279.
  47. Detailinformationen: Psychiatrie und Psychotherapie. Lieb K, Brunnhuber S: Psychiatrie und Psychotherapie.Urban und Fischer, 1999.
  48. Detailinformationen: Regulation of cyclooxygenase-2 in rat microglia: Role of MAP kinases ans spingomyelinases. Fiebich BL, Lieb K, Hüll M, Kreder D, Krönke M, Gebicke-Härter PJ: Regulation of cyclooxygenase-2 in rat microglia: Role of MAP kinases ans spingomyelinases. J Neurochem, 1999; 73: S79D.
  49. Detailinformationen: Regulation of substance P-induced cytokine expression in astrocytes. Lieb K, Czygan M, Craig A, Fiebich BL: Regulation of substance P-induced cytokine expression in astrocytes. Exp Clin Endocrinol Diabetes, 1999; 107 (Suppl.): 39-40.
  50. Detailinformationen: Substance P-receptor antagonists - a new strategy of antidepressant ans anxiolytic pharmacotherapy. Lieb K: Substance P-receptor antagonists - a new strategy of antidepressant ans anxiolytic pharmacotherapy. Pharmacopsychiat., 1999; 32: 195.
  51. Detailinformationen: The neuropeptide substance P activates p38 MAP-kinase resulting in interleukin-6 expression independently from nuclear factor-kappa B. Craig A, Czygan M, Butcher RD, Lieb K, Fiebich BL: The neuropeptide substance P activates p38 MAP-kinase resulting in interleukin-6 expression independently from nuclear factor-kappa B. J Neurochem, 1999; 73: S153D.
  52. Detailinformationen: The neuropeptide substance P activates p38 MAP-kinase that induces interleukin-6 expression in human astrocytoma cells independently from activation of nuclear factor-kappa B. Fiebich BL, Craig A, Butcher RD, Lieb K: The neuropeptide substance P activates p38 MAP-kinase that induces interleukin-6 expression in human astrocytoma cells independently from activation of nuclear factor-kappa B. Brain Res., 1999; 848: 25.
  53. Detailinformationen: The non-steroidal anti-inflammatory drug tepoxalin inhibits interleukin-6 und alpha1-anti-chymotrypsin synthesis in astrocytes by preventing degradation of IkB-alpha. Fiebich BL, Hofer TJ, Lieb K, Hüll M, Butcher RD, Schumann G, Schulze-Osthoff K, Bauer J: The non-steroidal anti-inflammatory drug tepoxalin inhibits interleukin-6 und alpha1-anti-chymotrypsin synthesis in astrocytes by preventing degradation of IkB-alpha. Neuropharmacology, 1999; 38: 1325-1333.
  54. Detailinformationen: Anti-inflammatory drugs: a hope for Alzheimer's disease? Hüll M, Lieb K, Fiebich BL: Anti-inflammatory drugs: a hope for Alzheimer's disease? Exp Opin Invest Drugs, 2000; 9 (4): 671-683.
  55. Detailinformationen: Demonstration of borna disease virus nucleic acid in a patinet with chronic fatigue syndrome. Staeheli P, Lieb K, Czygan M, Sauder C, Schwemmle M: Demonstration of borna disease virus nucleic acid in a patinet with chronic fatigue syndrome. J Infect Dis, 2000; 181: 1860-1861.
  56. Detailinformationen: Effects of caffeine and paracetamol alone or in combination with acetylsalicylic acid on PGE2-synthesis in rat microglial cells. Fiebich BL, Lieb K, Hüll M, Aicher B, Ryn v J, Pairet M, Engelhardt G: Effects of caffeine and paracetamol alone or in combination with acetylsalicylic acid on PGE2-synthesis in rat microglial cells. Neuropharmacology, 2000; 39: 2205-2213.
  57. Detailinformationen: Prefrontal cortical hypometabolism during low-dose interferon alpha treatment. Jüngling FD, Ebert D, Gut O, Engelbrecht MA, Rasenack J, Nitzsche EU, Bauer J, Lieb K: Prefrontal cortical hypometabolism during low-dose interferon alpha treatment. Neuropsychopharmacol, 2000; 152: 383-389.
  58. Detailinformationen: Protective role of neurotrophins in experimental inflammation of the rat gut. Reinshagen M, Rohm H, Steinkamp M, Lieb K, Geerling I, von Herbay A, Flämig G, Eysselein VE, Adler G: Protective role of neurotrophins in experimental inflammation of the rat gut. Gastroenterology, 2000; 119: 368-376.
  59. Detailinformationen: Sleep deprivation and growth-hormone secretion. Lieb K, Reincke M, Riemann D, Voderholzer U: Sleep deprivation and growth-hormone secretion. Lancet, 2000; 356: 2096-2097.
  60. Detailinformationen: Strategies to delay the onset of Alzheimer's disease.New approaches to drug development. Hüll M, Fiebich BL, Lieb K: Strategies to delay the onset of Alzheimer's disease. In: Jollès P (Hrsg.): New approaches to drug development. Birkhäuser Verlag, 2000; 211-225.
  61. Detailinformationen: Substanz P-Rezeptor-Antagonisten als neues antidepressives und anxiolytisches Wirkprinzip? Lieb K, Fiebich BL, Berger M: Substanz P-Rezeptor-Antagonisten als neues antidepressives und anxiolytisches Wirkprinzip? Nervenarzt, 2000; 71: 758-761.
  62. Detailinformationen: The neuropeptide substance P activitates p38 MAP kinase resulting in interleukin-6 expression independently from nuclear factor-kappa B. Fiebich BL, Schleicher S, Butcher RD, Craig A, Lieb K: The neuropeptide substance P activitates p38 MAP kinase resulting in interleukin-6 expression independently from nuclear factor-kappa B. J Immunol, 2000: 5606-5611.
  63. Detailinformationen: Borna disease virus - does it infect humans and cause psychiatric disorders? Lieb K, Staeheli P: Borna disease virus - does it infect humans and cause psychiatric disorders? J Clin Virol, 2001; 21: 119-127.
  64. Detailinformationen: Bornavirus and psychiatric disorders - fact or fiction? Staeheli P, Lieb K: Bornavirus and psychiatric disorders - fact or fiction? J Med Microbiol, 2001; 50: 1-3.
  65. Detailinformationen: Extrem ausgeprägte Insomnie im Rahmen einer cerebralen Whipple Erkrankung: Langzeitverlauf unter Therapie Voderholzer U, Riemann D, Gann H, Hornyak M, Berger M, Weske G, Lieb K: Extrem ausgeprägte Insomnie im Rahmen einer cerebralen Whipple Erkrankung: Langzeitverlauf unter Therapie Somnologie, 2001; 5: 56.
  66. Detailinformationen: Inhibition of substance p-induced cytokine synthesis by St. John's wort extracts. Fiebich BL, Höllig A, Lieb K: Inhibition of substance p-induced cytokine synthesis by St. John's wort extracts. Pharmacopsychiatry, 2001; 34 Suppl. 1: 26-28.
  67. Detailinformationen: Substanz P und neurogene Entzündung. Fiebich BL, Lieb K: Substanz P und neurogene Entzündung. Immunologie Aktuell, 2001; 1: 148-149.
  68. Detailinformationen: Subtle Prefrontal Neuropathology in a Pilot Magnetic Resonance Spectroscopy Study in Patients with Borderline Personality Disorder Tebartz van Elst L, Thiel T, Hesslinger B, Lieb K, Bohus M, Hennig J, Ebert D: Subtle Prefrontal Neuropathology in a Pilot Magnetic Resonance Spectroscopy Study in Patients with Borderline Personality Disorder J Neuropsych Clin N, 2001; 13 (4): 511-514.
  69. Detailinformationen: Volumes of the hippocampi and amygdalae in borderline personality disorder Rüsch N, Tebartz van Elst L, Thiel T, Heßlinger B, Lieb K, Bohus M, Ebert D: Volumes of the hippocampi and amygdalae in borderline personality disorder The World Journal of biological Psychiatry, 2001; 2 Suppl. 1: 247S-248S (7th World Congress of Biological Psychiatry), World federation of Societies of Biological Psychiatry (Hrsg).
  70. Detailinformationen: Zum Verständnis von Selbstverletzungen bei Patienten mit Borderline-Persönlichkeitsstörungen Bohus M, Lieb K: Zum Verständnis von Selbstverletzungen bei Patienten mit Borderline-Persönlichkeitsstörungen Zeitschrift für Allgemeinmedizin, 2001; 77: 539-547.
  71. Detailinformationen: 25 Fälle Psychatrie (zur Vorbereitung auf mündlcihe Prüfungen mit praxisnahen Fragen und ausführlichen Kommentaren) Lieb K, Heßlinger B, Frauenknecht S: 25 Fälle Psychatrie (zur Vorbereitung auf mündlcihe Prüfungen mit praxisnahen Fragen und ausführlichen Kommentaren), München, Jena: Urban & Fischer, 1. Auflage, 2002.
  72. Detailinformationen: Antagonisten am Substanz P-Rezeptor als neue Klasse von Antidepressiva. Lieb K, Herpfer I, Fiebich BL, Berger M: Antagonisten am Substanz P-Rezeptor als neue Klasse von Antidepressiva. Deut Med Wochenschr, 2002; 127: 2563-2565.
  73. Detailinformationen: Effects of the Neuropeptide Substance P on Sleep, Mood, and Neuroendocrine Measures in Healthy Young Men Lieb K, Ahlvers K, Dancker K, Strohbusch S, Reincke M, Feige B, Berger M, Riemann D, Voderholzer U: Effects of the Neuropeptide Substance P on Sleep, Mood, and Neuroendocrine Measures in Healthy Young Men Neuropsychopharmacol, 2002; 27 (6): 1041-1049.
  74. Detailinformationen: Increased plasma concentration of maprotiline by coadministration of risperidone Normann C, Lieb K, Walden J: Increased plasma concentration of maprotiline by coadministration of risperidone J Clin Psychopharm, 2002; 22: 92-93.
  75. Detailinformationen: Inhibition of LPS-induced p42/44 MAP kinase activation and iNOS/NO synthesis by parthenolide in rat primary microglial cells Fiebich BL, Lieb K, Engels S, Heinrich M: Inhibition of LPS-induced p42/44 MAP kinase activation and iNOS/NO synthesis by parthenolide in rat primary microglial cells J Neuroimmunol, 2002; 132: 18-24.
  76. Detailinformationen: Interferon alpha (IFN alpha) and psychiatric syndromes Schaefer M, Engelbrecht MA, Gut O, Fiebich BL, Bauer J, Schmidt F, Grunz H, Lieb K: Interferon alpha (IFN alpha) and psychiatric syndromes Prog Neuro-psychoph, 2002; 26: 731-746.
  77. Detailinformationen: Neuropeptid-Modulatoren - Psychopharmaka der Zukunft? Herpfer I, Lieb K: Neuropeptid-Modulatoren - Psychopharmaka der Zukunft? Psycho, 2002; 28: 517-521.
  78. Detailinformationen: Nonsteroidal drugs and the risk of Alzheimer's disease Hüll M, Lieb K, Fiebich B-L: Nonsteroidal drugs and the risk of Alzheimer's disease New Engl J Med, 2002; 346 (15): 1171-1172.
  79. Detailinformationen: Pathways of Inflammatory Activation in Alzheimer's Disease: Potential Targets for Disease Modifying Drugs Hüll M, Lieb K, Fiebich B-L: Pathways of Inflammatory Activation in Alzheimer's Disease: Potential Targets for Disease Modifying Drugs Curr Med Chem, 2002; 9: 83-88.
  80. Detailinformationen: Polysomnographic studies in female patients with borderline personality disorder: a comparison with healthy control subjects Philipsen A, Bohus B, Voderholzer U, Riemann D, Lieb K: Polysomnographic studies in female patients with borderline personality disorder: a comparison with healthy control subjects Eur Arch Psy Clin N, 2002; 252 Suppl. 1: 67-67 (8th Congress of the German Society for Biological Psychiatry), Gaebel W, Düsseldorf (Hrsg).
  81. Detailinformationen: Qualitätskriterien für Fortbildung Lieb K, Berner M, Berger M: Qualitätskriterien für Fortbildung Facts&Figures - Intern. Zeitschr. f. Ärztl. Fortbildung, 2002; 22: 22-25.
  82. Detailinformationen: Substance P and Affective Disorders: New Treatment Opportunities by Neurokinin 1 Receptor Antagonists? Lieb K, Treffurth Y, Berger M, Fiebich B-L: Substance P and Affective Disorders: New Treatment Opportunities by Neurokinin 1 Receptor Antagonists? Neuropsychobiology, 2002; 45 Suppl. 1: 2-6.
  83. Detailinformationen: Substanz P und Substanz-P-Rezeptoranagonisten in der Pathogenese und Therapie affektiver Störungen Lieb K, Herpfer I, Fiebich BL, Berger M: Substanz P und Substanz-P-Rezeptoranagonisten in der Pathogenese und Therapie affektiver Störungen Nervenheilkunde, 2002; 21: 493-496.
  84. Detailinformationen: Transient total sleep loss in cerebral Whipple's disease: a longitudinal study Voderholzer U, Riemann D, Gann H, Hornyak M, Juengling F, Schumacher M, Reincke M, von Herbay A, Nishino S, Mignot E, Berger M, Lieb K: Transient total sleep loss in cerebral Whipple's disease: a longitudinal study J Sleep Res, 2002; 11: 321-329.
  85. Detailinformationen: Akutbehandlung psychischer Erregungszustände: Was tun Sie, wenn der Patient tobt? Lieb K: Akutbehandlung psychischer Erregungszustände: Was tun Sie, wenn der Patient tobt? MMW Fortschr. Med., 2003; 38: 49-50.
  86. Detailinformationen: A voxel-based morphometric MRI study in female patients with borderline personality disorder Rüsch N, Tebartz van Elst L, Ludaescher P, Wilke M, Huppertz HJ, Thiel T, Schmahl C, Bohus M, Lieb K, Heßlinger B, Hennig J, Ebert D: A voxel-based morphometric MRI study in female patients with borderline personality disorder Neuroimage, 2003; 20: 385-392.
  87. Detailinformationen: A Voxel-based Morphometric MRI Study in Female Patients with Borderline Personality Disorder Rüsch N, Tebartz van Elst L, Wilke M, Lieb K, Bohus M, Ebert D: A Voxel-based Morphometric MRI Study in Female Patients with Borderline Personality Disorder 2003 (156th Annual Meeting of the American Psychiatric Association, San Francisco).
  88. Detailinformationen: Borderline-Persönlichkeitsstörung - eine polysomnographische Untersuchung im Vergleich zu gesunden Kontrolen Philipsen A, Voderholzer U, Feige B, Bohus M, Lieb K, Riemann D: Borderline-Persönlichkeitsstörung - eine polysomnographische Untersuchung im Vergleich zu gesunden Kontrolen Nervenarzt, 2003 Suppl. 2: 301-301.
  89. Detailinformationen: Frontolimbic brain abnormalities in patients with borderline personality disorder. A volumetric magnetic resonance imaging study Tebartz van Elst L, Hesslinger B, Thiel T, Geiger E, Haegele K, Lemieux L, Lieb K, Bohus M, Hennig J, Ebert D: Frontolimbic brain abnormalities in patients with borderline personality disorder. A volumetric magnetic resonance imaging study Biol Psychiat, 2003; 54: 163-171.
  90. Detailinformationen: Inhibition of LPS-induced iNOS and NO synthesis in primary rat microglial cells. Lieb K, Engels S, Fiebich BL: Inhibition of LPS-induced iNOS and NO synthesis in primary rat microglial cells. Neurochem Int, 2003; 42: 131-137.
  91. Detailinformationen: Neurokinin-1 receptor expression and its potential effects on tumor growth in human pancreatic cancer Friess H, Zhu Z, Liard V, Shi X, Shrikhande SV, Wang L, Lieb K, Korc K, Palma C, Zimmermann A, Reubi JC, Büchler MW: Neurokinin-1 receptor expression and its potential effects on tumor growth in human pancreatic cancer Lab Invest, 2003; 83: 731-742.
  92. Detailinformationen: Neurotransmitter changes by interferon-alpha and therapeutic implications. Schaefer M, Schwaiger M, Pich M, Lieb K, Heinz A: Neurotransmitter changes by interferon-alpha and therapeutic implications. Pharmacopsychiatry, 2003; 36 Suppl. 3: 203-206.
  93. Detailinformationen: Off-label-Indikationen in der Psychopharmakotherapie: ein Überblick Normann C, van Calker D, Voderholzer U, Fritze J, Lieb K: Off-label-Indikationen in der Psychopharmakotherapie: ein Überblick Nervenarzt, 2003; 74: 815-825.
  94. Detailinformationen: Positron emission tomography in female patients with Borderline personality disorder Juengling FD, Schmahl C, Heßlinger B, Ebert D, Bremner JD, Gostomzyk J, Bohus M, Lieb K: Positron emission tomography in female patients with Borderline personality disorder J Psychiat Res, 2003; 37: 109-115.
  95. Detailinformationen: Posttraumatische BelastungsstörungenPsychische Erkrankungen - Klinik und Therapie Frommberger U, Nyberg E, Angenendt J, Lieb K, Berger M: Posttraumatische Belastungsstörungen In: Berger M (Hrsg.): Psychische Erkrankungen - Klinik und Therapie München: Urban & Fischer, 2003; 716.
  96. Detailinformationen: Regloser Patient. Was tun bei stuporösen Zuständen? Lieb K: Regloser Patient. Was tun bei stuporösen Zuständen? MMW Fortschr. Med., 2003; 29: 42-44.
  97. Detailinformationen: Substance P and Substance P Receptor Antagonists in the Pathogenesis and Treatment of Affective Disorders Herpfer I, Lieb K: Substance P and Substance P Receptor Antagonists in the Pathogenesis and Treatment of Affective Disorders World J Biol Psychiatry, 2003; 4: 56-63.
  98. Detailinformationen: Subtype differentiation of patients with borderline personality disorder using a circumplex model of interpersonal behavior Leihener F, Wagner A, Haaf B, Schmidt C, Lieb K, Stieglitz R, Bohus M: Subtype differentiation of patients with borderline personality disorder using a circumplex model of interpersonal behavior J Nerv Ment Dis, 2003; 191: 248-254.
  99. Detailinformationen: Synergistic inhibitory effect of ascorbic acid and acetylsalicylic acid on prostaglandin E2 release in primary rat microglia Fiebich BL, Lieb K, Kammerer N, Hüll M: Synergistic inhibitory effect of ascorbic acid and acetylsalicylic acid on prostaglandin E2 release in primary rat microglia J Neurochem, 2003; 86 (1): 173-178.
  100. Detailinformationen: Valproic acid inhibits substance P-induced activation of protein kinase C epsilon and expression of the substance P-receptor Lieb K, Treffurth Y, Hamke M, Shankar Akundi R, von Kleinsorgen M, Fiebich BL: Valproic acid inhibits substance P-induced activation of protein kinase C epsilon and expression of the substance P-receptor J Neurochem, 2003; 86 (1): 69-76.
  101. Detailinformationen: 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline induced apoptosis in the human neuroblastoma cell line SK-N-SH Akundi RS, Macho A, Munoz E, Lieb K, Bringmann G, Clement HW, Hüll M, Fiebich BL: 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline induced apoptosis in the human neuroblastoma cell line SK-N-SH J Neurochem, 2004; 91 (2): 263-273.
  102. Detailinformationen: Akute Suizidalität [Fortbildung Notfallseminar] Lieb K: Akute Suizidalität [Fortbildung Notfallseminar] MMW Fortschr Med, 2004; 146: 294-295.
  103. Detailinformationen: Antiinflammatory effects of 5-HT3 receptor antagonists in lipopolysaccharide-stimulated primary human monocytes Fiebich BL, Akundi RS, Lieb K, Candelario-Jalil E, Gmeiner D, Haus U, Muller W, Stratz T, Munoz E: Antiinflammatory effects of 5-HT3 receptor antagonists in lipopolysaccharide-stimulated primary human monocytes Scand J Rheumatol, 2004; 119 Suppl. Suppl.: 28-32.
  104. Detailinformationen: Borderline personality disorder Lieb K, Zanarini M, Schmahl C, Linehan M, Bohus M: Borderline personality disorder Lancet, 2004; 364: 453-461.
  105. Detailinformationen: Borderline Persönlichkeitsstörung. Kasuistik: Ein schmaler Grat. Peters J, Lieb K: Borderline Persönlichkeitsstörung. Kasuistik: Ein schmaler Grat. Via medici, 2004; 1: 50-53.
  106. Detailinformationen: Clonidine in acute aversive inner tension and self-injurious behavior in female patients with borderline personality disorder Philipsen A, Richter H, Schmahl C, Petrs J, Rüsch N, Bohus M, Lieb K: Clonidine in acute aversive inner tension and self-injurious behavior in female patients with borderline personality disorder J Clin Psychiat, 2004; 65 (10): 1414-1419.
  107. Detailinformationen: Cognitive impairment in patients with chronic hepatitis treated with interferon alpha. Results from a prospective study Lieb K, Engelbrecht MA, Gut O, Fiebich BL, Bauer J, Janssen G, Schäfer M: Cognitive impairment in patients with chronic hepatitis treated with interferon alpha. Results from a prospective study Eur Psychiat, 2004. (in Druck)
  108. Detailinformationen: Differential nociceptive deficits in patients with borderline personality disorder and self-injurious behavior: Laser-evoked potentials, spatial discrimination of noxious stimuli, and pain ratings Schmahl C, Greffrath W, Baumgärtner U, Schlereth T, Magerl W, Philipsen A, Lieb K, Bohus M, Treede RD: Differential nociceptive deficits in patients with borderline personality disorder and self-injurious behavior: Laser-evoked potentials, spatial discrimination of noxious stimuli, and pain ratings Pain, 2004; 110 (1-2): 470-479.
  109. Detailinformationen: Effectiveness of inpatient dialectical behavioral therapy for borderline personality disorder - a controlled trial Bohus M, Haaf B, Simms T, Schmahl C, Unckel C, Lieb K, Linehan M: Effectiveness of inpatient dialectical behavioral therapy for borderline personality disorder - a controlled trial Behav Res Ther, 2004; 42: 487-499.
  110. Detailinformationen: Intensivkurs Psychiatrie und Psychotherapie Brunnhuber S, Frauenknecht S, Lieb K: Intensivkurs Psychiatrie und Psychotherapie, München: Urban und Fischer, 5. Auflage, 2004.
  111. Detailinformationen: Management der akuten Suizidalität Lieb K: Management der akuten Suizidalität MMW Fortschr Med, 2004; 146 (16): 51-52.
  112. Detailinformationen: Naloxone in the Treatment of Acute Dissociative States in Female Patients with Borderline Personality Disorder Philipsen A, Schmahl C, Lieb K: Naloxone in the Treatment of Acute Dissociative States in Female Patients with Borderline Personality Disorder Pharmacopsychiatry, 2004; 37: 196-199.
  113. Detailinformationen: ncreased diurnal salivary cortisol in women with Borderline personality disorder Lieb K, Rexhausen JE, Kahl KG, Schweiger U, Philipsen A, Hellhammer DH, Bohus M: ncreased diurnal salivary cortisol in women with Borderline personality disorder J Psychiat Res, 2004; 38: 559-565.
  114. Detailinformationen: Neurokinine in der Depressionstherapie Lieb K: Neurokinine in der Depressionstherapie Neurotransmitter, 2004; 15: 58-60.
  115. Detailinformationen: New developments in the neurobiology of borderline personality disorder Bohus M, Schmahl C, Lieb k: New developments in the neurobiology of borderline personality disorder Curr Psychiatry Rep, 2004; 6: 43-50.
  116. Detailinformationen: Serum levels of substance P and response to antidepressant pharmacotherapy Lieb K, Walden J, Grunze H, Fiebich BL, Berger M, Normann C: Serum levels of substance P and response to antidepressant pharmacotherapy Pharmacopsychiatry, 2004; 37: 238-239.
  117. Detailinformationen: Welche Rolle spielt Substanz P für die Entwicklung neuer Antidepressiva? Lieb K: Welche Rolle spielt Substanz P für die Entwicklung neuer Antidepressiva? Neurotransmitter, 2004. (in Druck)
  118. Detailinformationen: Affective dysregulation and dissociative experience in female patients with borderline personality disorder: a startle response study Ebner-Priemer UW, Badeck S, Beckmann C, Wagner A, Feige B, Weiss I, Lieb K, Bohus M: Affective dysregulation and dissociative experience in female patients with borderline personality disorder: a startle response study J Psychiat Res, 2005; 39 (1): 85-92.
  119. Detailinformationen: Deep brain stimulation for treatment of refractory depression Schläpfer TE, Lieb K: Deep brain stimulation for treatment of refractory depression Lancet, 2005; 366: 1420-1422.
  120. Detailinformationen: Dialektisch-behaviorale Therapie in der stationären Alkoholentwöhnung Mayer-Bruns F, Lieb K, Dannegger E, Jacob G: Dialektisch-behaviorale Therapie in der stationären Alkoholentwöhnung Nervenarzt, 2005; 76: 339-343.
  121. Detailinformationen: Effects of substance P and its antagonist L-733060 on long term potentiation in guinea pig hippocampal slices. Langosch JM, Kupferschmid S, Heinen M, Walden J, Herpfer I, Fiebich BL, Lieb K: Effects of substance P and its antagonist L-733060 on long term potentiation in guinea pig hippocampal slices. Prog Neuro-psychoph, 2005; 29 (2): 315-319.
  122. Detailinformationen: Increased delta-power and discrepancies in objective and subjective sleep measurements in borderline personality disorder Philipsen A, Feige B, Al-Shajlawi A, Schmahl C, Bohus M, Richter H, Voderholzer U, Lieb K, Riemann D: Increased delta-power and discrepancies in objective and subjective sleep measurements in borderline personality disorder J Psychiatr Res, 2005; 39 (5): 489-498.
  123. Detailinformationen: Intensivkurs Psychiatrie und Psychotherapie Brunnhuber S, Frauenknecht S, Lieb K: Intensivkurs Psychiatrie und Psychotherapie, München: Elsevier Urban& Fischer, 5. Auflage. Auflage, 2005.
  124. Detailinformationen: No modulatory effect of neurokinin-1 receptor antagonists on serotonin-uptake in human and rat brain synaptosomes Lieb K, Fiebich BL, Herpfer I, Mantovani M, Löffler M, Feuerstein T: No modulatory effect of neurokinin-1 receptor antagonists on serotonin-uptake in human and rat brain synaptosomes Eur Neuropsychopharm, 2005; 15 (6): 641-646.
  125. Detailinformationen: Serotonin via 5-HT receptors activates p38 mitogen-activated protein kinase and protein kinase C epsilon resulting in interleukin-6 synthesis in human U373 MG astrocytoma cells Lieb K, Biersack L, Waschbisch A, Orlikowski S, Akundi RS, Candelario-Jalil, Hüll M, Fiebich B: Serotonin via 5-HT receptors activates p38 mitogen-activated protein kinase and protein kinase C epsilon resulting in interleukin-6 synthesis in human U373 MG astrocytoma cells J Neurochem, 2005; 93 (3): 549-559.
  126. Detailinformationen: Signal transduction pathways regulating cyclooxygenase-2 in lipopolysaccharide-activated primary rat microglia Akundi RS, Candelario-Jalil E, Hess S, Hüll M, Lieb K, Gebicke-Haerter PJ, Fiebich BL: Signal transduction pathways regulating cyclooxygenase-2 in lipopolysaccharide-activated primary rat microglia Glia, 2005; 51 (3): 199-208.
  127. Detailinformationen: Sleep in adults with attention deficit/ hyperactivity disorder: a controlled polysomnographic study including spectral analysis of the sleep EEG Philipsen A, Feige B, Hesslinger B, Ebert D, Carl C, Hornyak M, Lieb K, Voderholuzer U, Riemann D: Sleep in adults with attention deficit/ hyperactivity disorder: a controlled polysomnographic study including spectral analysis of the sleep EEG Sleep, 2005; 28 (8): 877-884.
  128. Detailinformationen: Substance P receptor antagonists in psychiatry: rationale for development and therapeutic potential Herpfer I, Lieb K: Substance P receptor antagonists in psychiatry: rationale for development and therapeutic potential Cns Drugs, 2005; 19 (4): 275-293.
  129. Detailinformationen: The 5-HT3 receptor antagonist tropisetron inhibits T cell activation by targeting the calcineurin pathway De la Vega M, Munoz E, Calzado MA, Lieb K, Candelario-Jalil E, Gescheidmeir H, Farber L, Müller W, Stratz T, Fiebich BL: The 5-HT3 receptor antagonist tropisetron inhibits T cell activation by targeting the calcineurin pathway Biochem Pharmacol, 2005; 70 (3): 369-380.
  130. Detailinformationen: Zur pathophysiologischen Bedeutung der Amygdala in der Affektregulation bei psychischen Störungen Van Elst LT, Lieb K: Zur pathophysiologischen Bedeutung der Amygdala in der Affektregulation bei psychischen Störungen Nervenheilkunde, 2005; 24: 89-98.
  131. Detailinformationen: 50 Fälle Psychiatrie und Psychotherapie Lieb K, Hesslinger B, Jacob GA: 50 Fälle Psychiatrie und PsychotherapieUrban und Fischer, 2. Auflage. Auflage, 2006.
  132. Detailinformationen: Ascorbic acid enhances the inhibitory effect of aspirin on neuronal cyclooxygenase-2-mediated prostaglandin E (2) production Candelario-Jalil E, Akundi RS, Bhatia HS, Lieb K, Appel K, Munoz E, Hüll M, Fiebich BL: Ascorbic acid enhances the inhibitory effect of aspirin on neuronal cyclooxygenase-2-mediated prostaglandin E (2) production J Neuroimmunol, 2006; 174: 39-51.
  133. Detailinformationen: Borderline-Persönlichkeitsstörung Jacob GA, Lieb K: Borderline-Persönlichkeitsstörung Psychiatrie und Psychotherapie up2date, 2006. (in Druck)
  134. Detailinformationen: Cognitive impairment in patients with chronic hepatitis treated with interferon alpha Lieb K, Engelbrecht MA, Gut O, Fiebich BL, Bauer J, Janssen G, Schäfer M: Cognitive impairment in patients with chronic hepatitis treated with interferon alpha Eur Psychiat, 2006; 21: 204-210.
  135. Detailinformationen: Deep-brain stimulation for Parkinson´s disease Lieb K, Schlaepfer TE: Deep-brain stimulation for Parkinson´s disease New Engl J Med, 2006; 355 (21): 2256-2256.
  136. Detailinformationen: Gruppentherapiemodul zur Stärkung des Selbstwertes bei PatientInnen mit Borderline-Persönlichkeitsstörung Jacob GA, Richter H, Lammers CH, Bohus M, Lieb K: Gruppentherapiemodul zur Stärkung des Selbstwertes bei PatientInnen mit Borderline-Persönlichkeitsstörung Verhaltenstherapie, 2006. (in Druck)
  137. Detailinformationen: Increased nocturnal Interleukin-6 (IL-6) excretion in patients with primary insomnia: a pilot study Burgos I, Richter L, Fiebich B, Lieb K, Voderholzer U, Riemann D: Increased nocturnal Interleukin-6 (IL-6) excretion in patients with primary insomnia: a pilot study Brain Behav Immun, 2006; 20 (3): 246-253.
  138. Detailinformationen: Neural correlates of antinociception in borderline personality disorder Schmahl C, Bohus M, Esposito F, Treede RD, Di Salle F, Greffrath W, Ludäscher P, Jochims A, Lieb K, Scheffler K, Hennig J, Seifritz E: Neural correlates of antinociception in borderline personality disorder Arch Gen Psychiat, 2006; 63: 659-667.
  139. Detailinformationen: Nocturnal serum leptin values in chronic primary insomnia: a preliminary report Riemann D, Burgos I, Richter L, Klein T, Fiebich B, Feige B, Freyer T, Lieb K, Voderholzer U: Nocturnal serum leptin values in chronic primary insomnia: a preliminary report Somnologie, 2006; 10: 192-199.
  140. Detailinformationen: No response of plasma substance P, but delayed increase of interleukin-1 receptor antagonist to acute psychosocial stress Rohleder N, Wolf JM, Herpfer I, Fiebich BL, Kirschbaum C, Lieb K: No response of plasma substance P, but delayed increase of interleukin-1 receptor antagonist to acute psychosocial stress Life Sci, 2006; 78: 3082-3089.
  141. Detailinformationen: Self-stigma, empowerment, and perceived legitimacy of discrimination among women with mental illness Rüsch N, Lieb K, Bohus M, Corrigan PW: Self-stigma, empowerment, and perceived legitimacy of discrimination among women with mental illness Psychiat Serv, 2006; 57: 399-402.
  142. Detailinformationen: Self-stigma in women with borderline personality disorder and women with social phobia Rüsch N, Hölzer A, Hermann C, Schramm E, Jacob GA, Bohus M, Lieb K, Corrigan PW: Self-stigma in women with borderline personality disorder and women with social phobia J Nerv Ment Dis, 2006; 194: 766-773.
  143. Detailinformationen: Signaltransduktion der Substanz P vermittelten Geninduktion von IL-6Lehrbuch der klinischen Pathophysiologie komplexer chronischer Erkrankungen Fiebich BL, Herpfer I, Lieb K: Signaltransduktion der Substanz P vermittelten Geninduktion von IL-6 In: Straub R (Hrsg.): Lehrbuch der klinischen Pathophysiologie komplexer chronischer Erkrankungen Göttingen: Vandenhoeck & Rupprecht, 2006; 57-59.
  144. Detailinformationen: Substance P induces expression of the corticotropin releasing factor I by activation of the neurokinin-1 receptor Hamke M, Herpfer I, Lieb K, Wandelt C, Fiebich BL: Substance P induces expression of the corticotropin releasing factor I by activation of the neurokinin-1 receptor Brain Res, 2006; 1102: 135-144.
  145. Detailinformationen: Tiefenhirnstimulation bei psychiatrischen ErkrankungenHighlights in Psychiatrie und Psychotherapie 2005 - 2006 Voderholzer U, Schläpfer T, Lieb K: Tiefenhirnstimulation bei psychiatrischen Erkrankungen In: Berger M, Normann C (Hrsg.): Highlights in Psychiatrie und Psychotherapie 2005 - 2006 München: Elsevier Urban & Fischer, 2006; 52-62.
  146. Detailinformationen: Universitäre Privatisierung als Chance oder Alptraum? Aldenhoff J, Fritze J, Lieb K: Universitäre Privatisierung als Chance oder Alptraum? Nervenarzt, 2006; 77: 1393-1398.
  147. Detailinformationen: Wem gehört die Psychotherapie? Lieb K, Berger M: Wem gehört die Psychotherapie? Psychodynamische Psychotherapie, 2006; 5: 147-153.
  148. Detailinformationen: An intensive treatment program of interpersonal psychotherapy plus pharmacotherapy for depressed inpatients: acute and long-term results Schramm E, van Calker D, Dykierek P, Lieb K, Kech S, Zobel I, Leonhart R, Berger M: An intensive treatment program of interpersonal psychotherapy plus pharmacotherapy for depressed inpatients: acute and long-term results Am J Psychiat, 2007; 164: 768-777.
  149. Detailinformationen: Borderline-Persönlichkeitsstörung Jacob G, Lieb K: Borderline-Persönlichkeitsstörung Psychiatrie und Psychotherapie up2date, 2007; 1: 1-18.
  150. Detailinformationen: Corpus callosum abnormalities in women with borderline personality disorder and co-morbid attention deficit hyperactivity disorder Rüsch, N, Luders, E, Lieb, K, Zahn, R, Ebert, D, Thompson, PM, Toga, AW, Tebarzt van Elst, L: Corpus callosum abnormalities in women with borderline personality disorder and co-morbid attention deficit hyperactivity disorder J Psychiatr Neurosci, 2007; 32: 417-422.
  151. Detailinformationen: Effects of substance P on memory and mood in healthy male subjects Herpfer I, Katzev M, Feige B, Fiebich BL, Voderholzer U, Lieb K: Effects of substance P on memory and mood in healthy male subjects Hum Psychopharm Clin, 2007; 22: 567-573.
  152. Detailinformationen: Elevated pain thresholds correlate with dissociation and aversive arousal in patients with borderline personality disorder Ludäscher P, Bohus M, Lieb K, Philipsen A, Jochims C, Schmahl C: Elevated pain thresholds correlate with dissociation and aversive arousal in patients with borderline personality disorder Psychiat Res, 2007; 149: 291-296.
  153. Detailinformationen: Evidence of disturbed amygdalar energy metabolism in patients with borderline personality disorder Van Elst LT, Ludäscher P, Thiel T, Büchert M, Hesslinger B, Bohus M, Rüsch N, Hennig J, Ebert D, Lieb K: Evidence of disturbed amygdalar energy metabolism in patients with borderline personality disorder Neurosci Lett, 2007; 417: 36-41.
  154. Detailinformationen: Inferior frontal white matter microstructure and patterns of psychopathology in women with borderline personality disorder and comorbid attention deficit hyperactivity disorder Rüsch N, Weber K, Il´yasov K, Lieb K, Ebert D, Hennig J, van Elst TL: Inferior frontal white matter microstructure and patterns of psychopathology in women with borderline personality disorder and comorbid attention deficit hyperactivity disorder Neuroimage, 2007; 35: 738-747.
  155. Detailinformationen: Measuring shame and guilt by self-report questionnaires: a validation study Rüsch N, Corrigan PW, Bohus M, Jacob GA, Lieb K: Measuring shame and guilt by self-report questionnaires: a validation study Psychiat Res, 2007; 150: 313-325.
  156. Detailinformationen: On determining sensitivity to pain in borderline personality disorder - reply Schmahl C, Bohus M, Esposito F, Treede RD, DiSalle F, Greffrath W, Ludäscher P, Jochims A, Lieb K, Scheffler K, Hennig J, Seifritz E: On determining sensitivity to pain in borderline personality disorder - reply Arch Gen Psychiat, 2007; 64: 748-749.
  157. Detailinformationen: Schemnatherapie bei schweren Persönlichkeitsstörungen Jacob, G, Dieckmann, E, Lieb, K: Schemnatherapie bei schweren Persönlichkeitsstörungen INFO Neurologie & Psychiatrie, 2007; 9: 46-53.
  158. Detailinformationen: Shame and implicit self-concept in women with borderline personality disorder Rüsch N, Lieb K, Göttler I, Herrmann C, Schramm E, Richter H, Jacob GA, Corrigan PW, Bohus M: Shame and implicit self-concept in women with borderline personality disorder Am J Psychiat, 2007; 164: 500-508.
  159. Detailinformationen: State affective instability in borderline personality disorder assessed by ambulatory monitoring Ebner-Priemer, UW, Kuo, J, Kleindienst, N, Welch, SS, Reisch, T, Reinhard, I, Lieb, K, Linehan, MM, Bohus, M: State affective instability in borderline personality disorder assessed by ambulatory monitoring Psychol Med, 2007; 37: 961-970.
  160. Detailinformationen: The impact of posttraumatic stress disorder on dysfunctional implicit and explicit emotions among women with borderline personality disorder Rüsch N, Corrigan PW, Bohus M, Kühlert T, Jacob GA, Lieb K: The impact of posttraumatic stress disorder on dysfunctional implicit and explicit emotions among women with borderline personality disorder J Nerv Ment Dis, 2007; 195: 537-539.
  161. Detailinformationen: Verhaltenstherapie zur Steigerung des Selbstwertes bei Patienten mit Persönlichkeitsstörungen Jacob,G, Lieb, K: Verhaltenstherapie zur Steigerung des Selbstwertes bei Patienten mit Persönlichkeitsstörungen Persönlichkeitsstörungen, 2007; 11: 59-65.
  162. Detailinformationen: Verkürzung der Übermittlungszeit von Arztbriefen stationär behandelter Patienten in der Psychiatrie und Psychotherapie Lieb K, Trieschmann S, Buhl C, Vielhaber K, Mehraein S, Härter M: Verkürzung der Übermittlungszeit von Arztbriefen stationär behandelter Patienten in der Psychiatrie und Psychotherapie Nervenarzt, 2007; 78: 322-327.
  163. Detailinformationen: Attention deficit/hyperactivity disorder as a potentially aggravating factor in borderline personality disorders Philipsen, A, Limberger, K, Lieb, K, Feige, B, Kleindienst, N, Ebner-Priemer, U, Barth, J, Schmahl,C, Bohus, M: Attention deficit/hyperactivity disorder as a potentially aggravating factor in borderline personality disorders Brit J Psychiat, 2008; 192: 118-123.
  164. Detailinformationen: Neurochemical alterations in women with borderline personality disorder and co-morbid attention-deficit hyperactivity disorder. Rüsch, N, Boeker, M, Büchert, M, Glauche V, Bohrmann C, Ebert D, Lieb K, Hennig J, van Elst LT: Neurochemical alterations in women with borderline personality disorder and co-morbid attention-deficit hyperactivity disorder. World J Biol Psychia, 2008: 1-10. : http://dx.doi.org/10.1080/15622970801958331 (in Druck)
  165. Detailinformationen: Pharmakotherapie der Borderline-Persönlickeitsstörung. Evidenzbasierte Empfehlungen für den klinischen Alltag Stoffers, J, Lieb, K: Pharmakotherapie der Borderline-Persönlickeitsstörung. Evidenzbasierte Empfehlungen für den klinischen Alltag Info Neurologie & Psychiatrie, 2008; 10: 30-35.
  166. Detailinformationen: Predictors of dropout from inpatient dialectical behavior therapy among women with borderline personality disorder Rüsch, N, Schiel, S, Corrigan, PW, Leihener, F, Jacob, GA, Olschewski, M, Lieb, K, Bohus, M: Predictors of dropout from inpatient dialectical behavior therapy among women with borderline personality disorder J Behav Ther Exp Psy, 2008; 39: 497-503.
  167. Detailinformationen: Regulation of prostaglandin E (2) synthase expression in activated primary rat microglia: evidence for uncoupled regulation of mPGES-1 and COX-2 De Oliveira, AC, Candelario-Jalil, E, Bhatia, HS, Lieb, K, Hüll, M, Fiebich, BL: Regulation of prostaglandin E (2) synthase expression in activated primary rat microglia: evidence for uncoupled regulation of mPGES-1 and COX-2 Glia, 2008; 56: 844-855.
  168. Detailinformationen: Time courses of anger and other emotions in women with borderline personality disorder: a preliminary study Jacob, GA, Günzler, C, Zimmermann, S, Scheel, CN, Rüsch, N, Leonhart, R, Nerb, J, Lieb, K: Time courses of anger and other emotions in women with borderline personality disorder: a preliminary study J Behav Ther Exp Psy, 2008; 39: 391-402.
  169. Detailinformationen: Current status of inpatient treatment for borderline personality disorders in Germany Jacob, G, Allemann, R, Schornstein, K, Lieb, K: Current status of inpatient treatment for borderline personality disorders in Germany Psychiat Prax, 2009; 36: 387-389.
  170. Detailinformationen: Emotional reactions to standardized stimuli in women with borderline personality disorder Jacob, GA, Hellstern, K, Ower, N, Pillmann, M, Scheel, C, Rüsch, N, Lieb, K: Emotional reactions to standardized stimuli in women with borderline personality disorder J Nerv Ment Dis, 2009; 197: 808-815.
  171. Detailinformationen: Extraction of prefronto-amygdalar pathways by combining probability maps Bracht T, Tuscher O, Schnell S, Kreher B, Rüsch N, Glauche V, Lieb K, Ebert D, Il´yasov KA, Hennig C, Weiller C, van Elst LT, Saur D: Extraction of prefronto-amygdalar pathways by combining probability maps Psychiat Res, 2009; 174: 217-222. : http://dx.doi.org/10.1016/j.pscychresns.2009.05.001
  172. Detailinformationen: Posttraumatische BelastungsstörungenPsychische Erkrankungen Frommberger, U, Nyberg, E, Angenendt, J, Lieb, K, Berger, M: Posttraumatische Belastungsstörungen In: Berger, M unter Mitarbeit von Hecht, H (Hrsg.): Psychische Erkrankungen, 3.. Auflage. München, Jena: Elsevier/ Urban & Fischer, 2009; 667-696.
  173. Detailinformationen: Schematherapie mit dem Moduskonzept bei Persönlichkeitsstörungen Jacob, GA, Bernstein, D, Lieb, K, Arntz, A: Schematherapie mit dem Moduskonzept bei Persönlichkeitsstörungen Psychiatrie und Psychotherapie up2date, 2009; 3: 105-119.
  174. Detailinformationen: Schwierige Gesprächssituationen in Psychiatrie und Psychotherapie Jacob, GA, Lieb, K, Berger, M (Hrsg.): Schwierige Gesprächssituationen in Psychiatrie und Psychotherapie, München: Elsevier, 2009.
  175. Detailinformationen: Time course of response to antidepressants: predictive value of early improvement and effect of additional psychotherapy van Calker, D, Zobel, I, Dykierek, P, Deimel, CM,, Kech, S, Lieb, K, Berger, M, Schramm, E: Time course of response to antidepressants: predictive value of early improvement and effect of additional psychotherapy J Affect Disorders, 2009; 114: 243-253.
  176. Detailinformationen: Verhaltenstherapie zur Steigerung des Selbstwertes bei Patienten mit Persönlichkeitsstörungen Jacob GA, Lieb K: Verhaltenstherapie zur Steigerung des Selbstwertes bei Patienten mit Persönlichkeitsstörungen Persönlichkeitsstörungen Theorie und Therapie, 2009. (in Druck)
  177. Detailinformationen: Group therapy module to enhance self-esteem in patients with borderline personality disorder: a pilot study Jacob, GA, Gabriel, S, Roepke, S, Stoffers, J, Lieb, K, Lammers, CH: Group therapy module to enhance self-esteem in patients with borderline personality disorder: a pilot study Int J Group Psychoth, 2010; 60: 373-387.
  178. Detailinformationen: Impulsivity in borderline personality disorder: impairment in self-report measures, but not behavioral inhibition Jacob, G, Gutz, L, Bader, K, Lieb, K, Tüscher, O, Stahl, C: Impulsivity in borderline personality disorder: impairment in self-report measures, but not behavioral inhibition Psychopathology, 2010; 43: 180-188.
  179. Detailinformationen: Integrative PsychotherapiePsychiatrie und Psychotherapie Herpertz, S, Jacob, G, Külz, AK, Lieb, K, Schramm, E, Stoffers, J, Voderholzer, U: Integrative Psychotherapie In: Möller, HJ, Kasper, S, Laux, G (Hrsg.): Psychiatrie und Psychotherapie ???, 2010. (in Druck)
  180. Detailinformationen: Neurochemical alterations in women with borderline personality disorder comorbid with attention-deficit hyperactivity disorder Rüsch, N, Boeker, M, Büchert, M, Glauche, V, Bohrmann, C, Ebert, D, Lieb, K, Hennig, J, van Elst, LT: Neurochemical alterations in women with borderline personality disorder comorbid with attention-deficit hyperactivity disorder World J Biol Psychia, 2010; 11: 372-381.
  181. Detailinformationen: Pharmacological interventions for antisocial personality disorder Khalifa N, Duggan C, Stoffers J, Huband N, Völlm BA, Ferriter M, Lieb K: Pharmacological interventions for antisocial personality disorder Cochrane Db Syst Rev, 2010; 8 (online): CD007667. : http://dx.doi.org/10.1002/14651858.CD007667.pub2
  182. Detailinformationen: Pharmacological interventions for borderline personality disorders Stoffers J, Völlm BA, Rücker G, Timmer A, Huband N, Lieb K: Pharmacological interventions for borderline personality disorders Cochrane Db Syst Rev, 2010; 6 (online): CD005653.
  183. Detailinformationen: Pharmacotherapy for borderline personality disorder: cochrane systematic review of randomised trials Lieb K, Völlm B, Rücker G, Timmer A, Stoffers JM: Pharmacotherapy for borderline personality disorder: cochrane systematic review of randomised trials Brit J Psychiat, 2010; 196: 4-12.
  184. Detailinformationen: Psychological interventions for antisocial personality disorder. Gibbon S, Duggan C, Stoffers J, Huband N, Völlm BA, Ferriter M, Lieb K: Psychological interventions for antisocial personality disorder. Cochrane Db Syst Rev, 2010; 6 (online): CD007668cd. : http://dx.doi.org/10.1002/14651858.CD007668.pub2
  185. Detailinformationen: Rationale and design of the randomised clinical trial comparing early medication change (EMC) strategy with teratment as usual (TAU) in patients with major depressive disorder - the EMC trial Tadic A, Gorbulev S, Dahmen N, Hiemke C, Braus DF, Röschke J, van Calker D, Wachtlin D, Kronfeld K, Gorbauch T, Seibert-Grafe M, Lieb K, the EMC study group: Rationale and design of the randomised clinical trial comparing early medication change (EMC) strategy with teratment as usual (TAU) in patients with major depressive disorder - the EMC trial Trials, 2010; 26 (online): 21. : http://dx.doi.org/10.1186/1745-6215-11-21
  186. Detailinformationen: Reduced interhemispheric structural connectivity between anterior cingulate cortices in borderline personality disorder Rüsch N, Bracht T, Kreher BW, Schnell S, Glauche V, Il´yasov KA, Ebert D, Lieb K, Hennig J, Saur D, van Elst LT: Reduced interhemispheric structural connectivity between anterior cingulate cortices in borderline personality disorder Psychiat Res-neuroim, 2010; 181: 151-154. : http://dx.doi.org/10.1016/j.pscychresns.2009.08.004
  187. Detailinformationen: Comparison of different strategies to decerase negative affect and increase positive affect in women with borderline personality disorder Jacob, GA, Arendt, J, Kolley, L, Scheel, C, Bader, K, Lieb, K, Arntz, A, Tüscher, O: Comparison of different strategies to decerase negative affect and increase positive affect in women with borderline personality disorder Behav Res Ther, 2011; 49: 68-73.
  188. Detailinformationen: Early life stress stimulates hippocampal reelin gene expression in a sex-specific manner: evidence for corticosterone-mediated action Gross, CM, Flubacher, A, Tinnes, S, Heyer, A, Scheller, M, Herpfer, I, Berger, M, Frotscher, M, Lieb, K, Haas, CA: Early life stress stimulates hippocampal reelin gene expression in a sex-specific manner: evidence for corticosterone-mediated action Hippocampus, 2012. (in Druck)
  189. Detailinformationen: Effects of sleep deprivation on nocturnal cytokine concentrations in depressed patients and healthy controls Voderholzer, U, Fiebich, BL, Dersch, R, Feige, B, Kopasz, M, Riemann, D, Lieb, K: Effects of sleep deprivation on nocturnal cytokine concentrations in depressed patients and healthy controls J Neuropsych Clin N, 2012. (in Druck)
  190. Detailinformationen: Evaluation of naltrexone for dissociative symptoms in borderline personality disoder Schmahl, C, Kleindienst, N, Limberger, M, Ludäscher, P, Mauchnik, J, Deibler, P, Brünen, S, Hiemke, C, Lieb, K, Herpertz, S, Reicherzer, M, Berger, M, Bohus, M: Evaluation of naltrexone for dissociative symptoms in borderline personality disoder Int Clin Psychopharm, 2012; 27: 61-68.
  191. Detailinformationen: Medial prefrontal dysfunction and prolonged amygdala response during instructed fear processing in Borderline Personality Disorder Kamphausen, S, Schröder, P, Maier, S, Bader, KF, Feige, F, Kaller, C, Glauche, V, Ohlendorf, S, Tebartz van Elst, L, Klöppel, S, Jacob, G, Silbersweig, D, Lieb, K, Tüscher, O: Medial prefrontal dysfunction and prolonged amygdala response during instructed fear processing in Borderline Personality Disorder World J Biol Psychia, 2012. (in Druck)
  192. Detailinformationen: Neural correlates of interference inhibition, action withholding and action cancellation in adult ADHD Sebastian, A, Gerdesa, B, Klöppel, S, Langeb, T, Philipsen, A, Tebartz van Elst, L, Lieb, K, Tüscher, O: Neural correlates of interference inhibition, action withholding and action cancellation in adult ADHD Psychiat Res-neuroim, 2012. (in Druck)
  193. Detailinformationen: Small amygdala - high aggression? The role of the amygdala in modulating aggression in healthy subjects Matthies, S, Rüsch, N, Weber, M, Lieb, K, Philipsen, A, Tüscher, O, Ebert, D, Hennig, J, Tebartz van Elst, L: Small amygdala - high aggression? The role of the amygdala in modulating aggression in healthy subjects World J Biol Psychia, 2012; 13: 75-81.

    Institut für Psychologie, Abteilung für Klinische Psychologie und Psychotherapie

  1. Detailinformationen: Sleep in Adults with Attention Deficit Hyperactivity Disorder (ADHD): A Controlled Polysomnographic Study including Spectral Analysis of the sleep EEG Philipsen, A., Feige, B., Hesslinger, B., Ebert, E., Carl, C., Hornyak, M., Lieb, K., Voderholzer, U., & Riemann, D.: Sleep in Adults with Attention Deficit Hyperactivity Disorder (ADHD): A Controlled Polysomnographic Study including Spectral Analysis of the sleep EEG Sleep, 2005; 28: 877-884.
  2. Detailinformationen: Comparison of different strategies to decrease negative affect and increase positive affect in women with borderline personality disorder Jacob G.A., Arendt J., Kolley L., Scheel C.N., Bader K., Lieb K., Arntz A., Tüscher O.: Comparison of different strategies to decrease negative affect and increase positive affect in women with borderline personality disorder Behav Res Ther, 2011; 49: 68-73.
  3. Detailinformationen: Integrative PsychotherapiePsychiatrie, Psychosomatik und Psychotherapie Herpetz S.C., Jacob G., Külz A.-K., Lieb K., Schramm E., Stoffers J, Voderholzer U: Integrative Psychotherapie In: Psychiatrie, Psychosomatik und Psychotherapie, 4. Auflage. Heidelberg: Springer, 2011; 895-932.
  4. Detailinformationen: Schematherapie bei Borderline-Persönlichkeitsstörung.Fortschritte der Schematherapie Jacob G.A., Lieb K.: Schematherapie bei Borderline-Persönlichkeitsstörung. In: Fortschritte der Schematherapie Göttingen: Hogrefe, 2011; 122-130.
  5. Detailinformationen: Schematherapie bei Borderline-PersönlichkeitsstörungHandbuch Borderline-Störungen, 2., vollst. überarb. u. erw. Aufl. Jacob, G. A., Lieb, K., Arntz, A.: Schematherapie bei Borderline-Persönlichkeitsstörung In: B. Dulz, S. C. Herpertz, O. Kernberg, U. Sachsse (Hrsg.): Handbuch Borderline-Störungen, 2., vollst. überarb. u. erw. Aufl. Stuttgart: Schattauer, 2011; 640-651.
  6. Detailinformationen: Medial prefrontal dysfunction and prolonged amygdala response during instructed fear processing in borderline personality disorder. Kamphausen, S., Schroeder, P., Maier, S., Bader, K., Feige, B., Kaller, C. P., Glauche, V., Ohlendorf, S., Tebartz von Elst, L., Klöppel, S., Jacob, G. A., Silbersweig, D., Lieb, K., Tüscher, O.: Medial prefrontal dysfunction and prolonged amygdala response during instructed fear processing in borderline personality disorder. World J Biol Psychia, 2012. (in Druck)

    SFB 364 "Molekulare und zelluläre Grundlagen der Tumortherapie",

  1. Detailinformationen: IL-1 and TNF , but not IL-6, induce 1-antichymotrypsin expression in the human astrocytoma cell line U373 MG. Machein U., Lieb K., Huell M. and Fiebich B.L.: IL-1 and TNF , but not IL-6, induce 1-antichymotrypsin expression in the human astrocytoma cell line U373 MG. Neuroreport, 1995; 6: 2283-2286.
  2. Detailinformationen: Stimulation of the sphingomyelin pathway induces IL-6 gene expression in human astrocytoma cells. Fiebich B.L., Lieb K., Berger M., and Bauer J.: Stimulation of the sphingomyelin pathway induces IL-6 gene expression in human astrocytoma cells. J. Neuroimmunol., 1995; 63: 207-211.
  3. Detailinformationen: The Neuropeptide Substance P Activates Transcription Factor NF-kB and kB-Dependent Gene Expression in Human Astrocytoma Cells. Lieb K, Fiebich B L, Berger M, Bauer J, Schulze-Osthoff K: The Neuropeptide Substance P Activates Transcription Factor NF-kB and kB-Dependent Gene Expression in Human Astrocytoma Cells. The Journal of Immunology, 1997; 159: 4952-4958.

    Zentrum für Geriatrie und Gerontologie Freiburg, der Albert-Ludwigs-Universität

  1. Detailinformationen: Demenzerkrankungen Diagnose, Differentialdiagnose und Therapie. Rösler M., Lieb K., Wolf R., Berger M., Bauer J.: Demenzerkrankungen Diagnose, Differentialdiagnose und Therapie. Fortschritte der Medizin, 1996.
  2. Detailinformationen: Demenzerkrankungen - Diagnosen - Differentialdiagnose und Therapie. Rösler M, Hüll M, Lieb K, Wolf R, Berger M, Bauer J: Demenzerkrankungen - Diagnosen - Differentialdiagnose und Therapie. Fortschr Med, 1997; 114. (in Druck)

    Medizinische Universitätsklinik, Abteilung Rheumatologie und Klinische Immunologie

  1. Detailinformationen: Immunologische Systemerkrankungen als Differentialdiagnose in der Psychiatrie. Lieb K, Vaith P, Berger M, Bauer J: Immunologische Systemerkrankungen als Differentialdiagnose in der Psychiatrie. Nervenarzt, 1997; 68: 696-707.

    Neurologische Universitätsklinik und Poliklinik, Abteilung Neurologie und Neurophysiologie

  1. Detailinformationen: Impairment in preattentive visual processing in patients with Parkinson´s disease. Lieb K, Brucker S, Bach M, Els T, Lücking CH, Greenlee MW: Impairment in preattentive visual processing in patients with Parkinson´s disease. Brain, 1999; 122: 303-313.
  2. Detailinformationen: Pain perception during self-reported distress and calmness in patients with borderline personality disorder and self-mutilating behavior Bohus M, Limberger M, Ebner U, Glocker FX, Schwarz B, Wernz M, Lieb K: Pain perception during self-reported distress and calmness in patients with borderline personality disorder and self-mutilating behavior Psychiat Res, 2000; 95: 251-260.
  3. Detailinformationen: Effects of substance P on memory and mood in healthy male subjects. Herpfer I, Katzev M, Feige B, Fiebich BL, Voderholzer U, Lieb K: Effects of substance P on memory and mood in healthy male subjects. Hum Psychopharmacol, 2007; 22 (8): 567-573.
  4. Detailinformationen: Extraction of prefronto-amygdalar pathways by combining probability maps. Bracht T, Tuscher O, Schnell S, Kreher B, Rusch N, Glauche V, Lieb K, Ebert D, Il'yasov KA, Hennig J, Weiller C, van Elst LT, Saur D: Extraction of prefronto-amygdalar pathways by combining probability maps. Psychiat Res, 2009; 174 (3): 217-222. : http://dx.doi.org/10.1016/j.pscychresns.2009.05.001
  5. Detailinformationen: Comparison of different strategies to decrease negative affect and increase positive affect in women with borderline personality disorder. Jacob GA, Arendt J, Kolley L, Scheel CN, Bader K, Lieb K, Arntz A, Tuscher O: Comparison of different strategies to decrease negative affect and increase positive affect in women with borderline personality disorder. Behav Res Ther, 2010; 49 (1): 68-73. : http://dx.doi.org/10.1016/j.brat.2010.10.005
  6. Detailinformationen: Impulsivity in borderline personality disorder: impairment in self-report measures, but not behavioral inhibition. Jacob GA, Gutz L, Bader K, Lieb K, Tuscher O, Stahl C: Impulsivity in borderline personality disorder: impairment in self-report measures, but not behavioral inhibition. Psychopathology, 2010; 43 (3): 180-188. : http://dx.doi.org/10.1159/000304174
  7. Detailinformationen: Reduced interhemispheric structural connectivity between anterior cingulate cortices in borderline personality disorder. Rüsch N, Bracht T, Kreher BW, Schnell S, Glauche V, Il'yasov KA, Ebert D, Lieb K, Hennig J, Saur D *, van Elst LT *: Reduced interhemispheric structural connectivity between anterior cingulate cortices in borderline personality disorder. Psychiat Res-neuroim, 2010; 181 (2): 151-154. : http://dx.doi.org/10.1016/j.pscychresns.2009.08.004

    Radiologische Klinik, Nuklearmedizin

  1. Detailinformationen: Interferon-alpha/beta induced changes in cerebral glucose metabolism as measured by positron emission tomography. Lieb K., Jüngling FD., Brandt C., Lücking CH., Berger M., Bauer J.: Interferon-alpha/beta induced changes in cerebral glucose metabolism as measured by positron emission tomography. Eur Arch Psych Clin Neurosci, 1998; 248: 135.
  2. Detailinformationen: Cortical Dysfunction in Patients treated with low-dosage IFN-alpha Juengling FD, Gut O, Engelbrecht MA, Blum HE, Bauer J, Moser E, Nitzsche EU, Lieb K: Cortical Dysfunction in Patients treated with low-dosage IFN-alpha NeuroImage, 1999: 570.
  3. Detailinformationen: FDG-PET zum Nachweis IFN-Alpha assoziierter zerebraler Glukose-stoffwechselstörungen Juengling FD, Lieb K, Gut O, Bauer J, Moser E, Nitzsche EU: FDG-PET zum Nachweis IFN-Alpha assoziierter zerebraler Glukose-stoffwechselstörungen Nuklearmedizin, 1999; 2: A21.
  4. Detailinformationen: Prefrontal cortical hypometabolism during low-dose Interferon alpha treatment Juengling FD, Ebert D, Gut O, Engelbrecht MA, Rasenack J, Nitzsche EU, Bauer J, Lieb K: Prefrontal cortical hypometabolism during low-dose Interferon alpha treatment Psychopharmacology, 2000; 152 (4): 383-389.

    Institut für Medizinische Mikrobiologie und Hygiene, Abteilung Virologie

  1. Detailinformationen: Depression, Borna disease, and amantadine. Lieb K, Hufert FT, Bechter K, Bauer J, Kornhuber J: Depression, Borna disease, and amantadine. Lancet, 1997; 349: 958.
  2. Detailinformationen: No Borna disease virus-specific RNA detected in blood from psychiatric patients in different regions of Germany. Lieb K., Hallensleben W., Czygan M., Atitz L., Staeheli P.: No Borna disease virus-specific RNA detected in blood from psychiatric patients in different regions of Germany. The Lancet, 1997; 350: 1002.
  3. Detailinformationen: Borna Disease Virus und psychiatrische Erkrankungen. Lieb K., Czygan M., Sauder C., Hallensleben W., Staeheli P.: Borna Disease Virus und psychiatrische Erkrankungen. Deut Med Wochenschr, 1998; 123: 1217-1218.
  4. Detailinformationen: Bornaviren und psychiatrische Erkrankungen: Zusammenhänge weiterhin unklar Stäheli P., Lieb K.: Bornaviren und psychiatrische Erkrankungen: Zusammenhänge weiterhin unklar IKMI, 1998; 3: 2.
  5. Detailinformationen: Bornaviren - Ursache psychiatrischer Erkrankungen? Lieb K., Staeheli P.: Bornaviren - Ursache psychiatrischer Erkrankungen? Ars Medici, 1998; 17: 1077-1079.
  6. Detailinformationen: Borna disease virusin human brains with a rare form of hippocampal degeneration but not in brains of patients with common neuropsychiatric disorders. Czygan M., Hallensleben W., Hofer M., Pollk S., Sauder C., Bilzer T., Blümcke I., Riederer P., Bogert B., Falkai P., Schwarz M.J., Masliah E., Staeheli P., Hufert F.T., Lieb K.: Borna disease virusin human brains with a rare form of hippocampal degeneration but not in brains of patients with common neuropsychiatric disorders. J Infect Dis, 1999; 180: 1695-1699.
  7. Detailinformationen: Demonstration of Borna Disease Virus Nucleic Acid in a Patient with chronic fatigue syndrome. Reply to the Editor. Staeheli P., Lieb K., Czygan M., Sauder C., Schwemmle M.: Demonstration of Borna Disease Virus Nucleic Acid in a Patient with chronic fatigue syndrome. Reply to the Editor. J Infect Dis, 2000; 181: 1861-1862.
  8. Detailinformationen: Borna disease virus - does it infect humans and cause psychiatric disorders? Lieb K, Staeheli P.: Borna disease virus - does it infect humans and cause psychiatric disorders? J Clin Virol, 2001; 21: 119-127.
  9. Detailinformationen: Bornavirus and psychiatric disorders - fact or fiction? Staeheli P, Lieb K.: Bornavirus and psychiatric disorders - fact or fiction? J Med Microbiol, 2001; 50: 579-581.

    Augenklinik, Abteilung Neuroophthalmologie und Schielbehandlung

  1. Detailinformationen: Impairment in preattentive visual processing in patients with Parkinson's disease Lieb K, Brucker S, Bach M, Els T, Lücking CH, Greenlee MW: Impairment in preattentive visual processing in patients with Parkinson's disease Brain, 1999; 122: 303-313.

    Medizinische Universitätsklinik, Abteilung Innere Medizin II

  1. Detailinformationen: Prefrontal cortical hypometabolism during low-dose interferon alpha treatment. Juengling FD, Ebert D, Gut O, Engelbrecht MA, Rasenack J, Nitzsche EU, Bauer J, Lieb K: Prefrontal cortical hypometabolism during low-dose interferon alpha treatment. Psychopharmacology, 2000; 152 (4): 383-389.
  2. Detailinformationen: Sleep deprivation and growth-hormone secretion. Lieb K, Reincke M, Riemann D, Voderholzer U: Sleep deprivation and growth-hormone secretion. Lancet, 2000; 356 (9247): 2096-2097.
  3. Detailinformationen: Effects of the neuropeptide substance P on sleep, mood, and neuroendocrine measures in healthy young men. Lieb K, Ahlvers K, Dancker K, Strohbusch S, Reincke M, Feige B, Berger M, Riemann D, Voderholzer U: Effects of the neuropeptide substance P on sleep, mood, and neuroendocrine measures in healthy young men. Neuropsychopharmacol, 2002; 27 (6): 1041-1049.
  4. Detailinformationen: Transient total sleep loss in cerebral Whipple's disease: a longitudinal study. Voderholzer U, Riemann D, Gann H, Hornyak M, Juengling F, Schumacher M, Reincke M, Von Herbay A, Nishino S, Mignot E, Berger M, Lieb K: Transient total sleep loss in cerebral Whipple's disease: a longitudinal study. J Sleep Res, 2002; 11 (4): 321-329.
  5. Detailinformationen: Non-medical use of prescription stimulants and illicit use of stimulants for cognitive enhancement in pupils and students in Germany. Franke AG, Bonertz C, Christmann M, Huss M, Fellgiebel A, Hildt E, Lieb K: Non-medical use of prescription stimulants and illicit use of stimulants for cognitive enhancement in pupils and students in Germany. Pharmacopsychiatry, 2011; 44 (2): 60-66. : http://dx.doi.org/10.1055/s-0030-1268417

    Radiologische Universitätsklinik, Abteilung Röntgendiagnostik

  1. Detailinformationen: Subtle prefrontal neuropathology in a pilot magnetic resonance spectroscopy study in patients with borderline personality disorder. van Elst LT, Thiel T, Hesslinger B, Lieb K, Bohus M, Hennig J, Ebert D.: Subtle prefrontal neuropathology in a pilot magnetic resonance spectroscopy study in patients with borderline personality disorder. J Neuropsych Clin N, 2001; 13 (4): 511-514.
  2. Detailinformationen: Frontolimbic Brain Abnormalities in Patients with Borderline Personality Disorder. A Volumetric MRI Study. van Elst LT, Hesslinger B, Thiel T, Geiger E, Haegele K, Lemieux L, Lieb K, Bohus M, Hennig J, Ebert D.: Frontolimbic Brain Abnormalities in Patients with Borderline Personality Disorder. A Volumetric MRI Study. Biol Psychiat, 2002. (in Druck)
  3. Detailinformationen: A voxel-based morphometric MRI study in female patients with borderline personality disorder. Rüsch N, van Elst LT, Ludaescher P, Wilke M, Huppertz HJ, Thiel T, Schmahl C, Bohus M, Lieb K, Heßlinger J, Hennig J, Ebert D.: A voxel-based morphometric MRI study in female patients with borderline personality disorder. Neuroimage, 2003; 20 (1): 385-392.
  4. Detailinformationen: Frontolimbic Brain Abnormalities in Patients with Borderline Personality Disorder. A Volumetric MRI Study. van Elst LT, Hesslinger B, Thiel T, Geiger E, Haegele K, Lemieux L, Lieb K, Bohus M, Hennig J, Ebert D.: Frontolimbic Brain Abnormalities in Patients with Borderline Personality Disorder. A Volumetric MRI Study. Biol Psychiat, 2003; 54 (2): 163-171.
  5. Detailinformationen: Neural correlates of antinociception in borderline personality disorder. Schmahl C, Bohus M, Esposito F, Treede RD, Di Salle F, Greffrath W, Ludaescher P, Jochims A, Lieb K, Scheffler K, Hennig J, Seifritz E.: Neural correlates of antinociception in borderline personality disorder. Arch Gen Psychiat, 2006; 63 (6): 659-667.
  6. Detailinformationen: Evidence of disturbed amygdalar energy metabolism in patients with borderline personality disorder. Tebartz van Elst L, Ludaescher P, Thiel T, Büchert M, Hesslinger B, Bohus M, Rüsch N, Hennig J, Ebert D, Lieb K.: Evidence of disturbed amygdalar energy metabolism in patients with borderline personality disorder. Neurosci Lett, 2007; 417 (1): 36-41.
  7. Detailinformationen: Inferior frontal white matter microstructure and patterns of psychopathology in women with borderline personality disorder and comorbid attention-deficit hyperactivity disorder. Rusch N, Weber M, Il'yasov KA, Lieb K, Ebert D, Hennig J, Tebartz van Elst L.: Inferior frontal white matter microstructure and patterns of psychopathology in women with borderline personality disorder and comorbid attention-deficit hyperactivity disorder. Neuroimage, 2007; 35 (2): 738-747.
  8. Detailinformationen: Early Life Stress: Longitudinal Monitoring of Morphological Impact on the Hippocampus Hsing in Vivo MR-Imaging in Mouse Model. Reichardt W, Gross C, Herpfer I, Haas C, Lieb K, von Elverfeldt D.: Early Life Stress: Longitudinal Monitoring of Morphological Impact on the Hippocampus Hsing in Vivo MR-Imaging in Mouse Model. Proc. 16th Ann Scientific Meeting International Society for Magnetic Resonance in Medicine, 2008: 2307 (16th Ann Scientific Meeting of the International Society for Magnetic Resonance in Medicine (ISMRM), Toronto (03.-09.05.2008)).
  9. Detailinformationen: Neurochemical alterations in women with borderline personality disorder and comorbid attention-deficit hyperactivity disorder. Rüsch N, Boeker M, Büchert M, Glauche V, Bohrmann C, Ebert D, Lieb K, Hennig J, Van Elst LT.: Neurochemical alterations in women with borderline personality disorder and comorbid attention-deficit hyperactivity disorder. World J Biol Psychia, 2008: 1-10. : http://dx.doi.org/10.1080/15622970801958331 (in Druck)
  10. Detailinformationen: Extraction of prefronto-amygdalar pathways by combining probability maps. Bracht T, Tuscher O, Schnell S, Kreher B, Rusch N, Glauche V, Lieb K, Ebert D, Il'yasov KA, Hennig J, Weiller C, van Elst LT, Saur D.: Extraction of prefronto-amygdalar pathways by combining probability maps. Psychiat Res, 2009; 174 (3): 217-222. : http://dx.doi.org/10.1016/j.pscychresns.2009.05.001
  11. Detailinformationen: Neurochemical alterations in women with borderline personality disorder and comorbid attention-deficit hyperactivity disorder Rusch, N., Boeker, M., Buchert, M., Glauche, V., Bohrmann, C., Ebert, D., Lieb, K., Hennig, J., Tebartz Van Elst, L.: Neurochemical alterations in women with borderline personality disorder and comorbid attention-deficit hyperactivity disorder World J Biol Psychia, 2010; 11 (2 Pt 2): 372-381. : http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=20218799
  12. Detailinformationen: Reduced interhemispheric structural connectivity between anterior cingulate cortices in borderline personality disorder Rüsch N, Bracht T, Kreher B W, Schnell S, Glauche V, Il'yasov K A, Ebert D, Lieb K, Hennig J, Saur D, van Elst L T: Reduced interhemispheric structural connectivity between anterior cingulate cortices in borderline personality disorder Psychiat Res-neuroim, 2010; 181 (2): 151-154. : http://dx.doi.org/10.1016/j.pscychresns.2009.08.004

    Universitätsklinik für Psychiatrie und Psychosomatik, Abteilung für Psychosomatische Medizin und Psychotherapie

  1. Detailinformationen: Anti-inflammatory substances - a new therapeutic option in Alzheimers's disease Hull M, Fiebich BL, Schumann G, Lieb K, Bauer J: Anti-inflammatory substances - a new therapeutic option in Alzheimers's disease Drug Discov Today, 1999; 4 (6): 275-282.
  2. Detailinformationen: The non-steroidal anti-inflammatory drug tepoxalin inhibits interleukin-6 and alpha1-antichymotrypsin synthesis in astrocytes by preventing degradation of IkappaB-alpha. Fiebich BL, Hofer TJ, Lieb K, Huell M, Butcher RD, Schumann G, Schulze-Osthoff K, Bauer J: The non-steroidal anti-inflammatory drug tepoxalin inhibits interleukin-6 and alpha1-antichymotrypsin synthesis in astrocytes by preventing degradation of IkappaB-alpha. Neuropharmacology, 1999; 38 (9): 1325-1333.
  3. Detailinformationen: Prefrontal cortical hypometabolism during low-dose interferon alpha treatment Jüngling FD, Ebert D, Gut O, Engelbrecht MA, Rasenack J, Nitzsche EU, Bauer J, Lieb K: Prefrontal cortical hypometabolism during low-dose interferon alpha treatment Psychopharmacology, 2000; 152 (4): 383-389.
  4. Detailinformationen: Cognitive impairment in patients with chronic hepatitis treated with low-dose interferon alpha: results from a prospective study. Lieb K, Engelbrecht MA, Gut O, Fiebich BL, Bauer J: Cognitive impairment in patients with chronic hepatitis treated with low-dose interferon alpha: results from a prospective study. ., 2002. (in Druck)
  5. Detailinformationen: Interferon alpha and psychiaric syndromes Schaefer M, Engelbrecht MA, Gut O, Fiebich BL, Bauer J, Schmidt F, Grunze H, Lieb K: Interferon alpha and psychiaric syndromes Prog Neuro-psychoph, 2002; 26: 731-746.

    Abteilung für Neuroradiologie,

  1. Detailinformationen: Transient total sleep loss in cerebral Whipple's disease: a longitudinal study Voderholzer U, Riemann D, Gann H, Hornyak M, Jüngling F, Schumacher M, Reincke M, von Herbay A, Nishino S, Mignot E, Berger M, Lieb K: Transient total sleep loss in cerebral Whipple's disease: a longitudinal study J Sleep Res, 2002; 11: 321-329.

    Neurochirurgische Universitätsklinik, Sektion Epileptologie

  1. Detailinformationen: A voxel-based morphometric MRI study in female patients with borderline personality disorder. Rusch N, van Elst LT, Ludaescher P, Wilke M, Huppertz HJ, Thiel T, Schmahl C, Bohus M, Lieb K, Hesslinger B, Hennig J, Ebert D: A voxel-based morphometric MRI study in female patients with borderline personality disorder. Neuroimage, 2003; 20 (1): 385-392.

    Universitätsklinik für Psychiatrie und Psychosomatik, Abteilung für Psychiatrie und Psychotherapie im Kindes- und Jugendalter

  1. Detailinformationen: 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline-induced apoptosis in the human neuroblastoma cell line SK-N-SH Akundi RS, Macho A, Munoz E, Lieb K, Bringmann G, Clement HW, Hull M, Fiebich BL: 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline-induced apoptosis in the human neuroblastoma cell line SK-N-SH J Neurochem, 2004; 91 (2): 263-273.

    Neurochirurgische Universitätsklinik, Abteilung Allgemeine Neurochirurgie mit Poliklinik

  1. Detailinformationen: No modulatory effect of neurokinin-1 receptor antagonists on serotonin uptake in human and rat brain synaptosomes. Lieb K, Fiebich BL, Herpfer I, Mantovani M, Loffler M, Feuerstein TJ: No modulatory effect of neurokinin-1 receptor antagonists on serotonin uptake in human and rat brain synaptosomes. Eur Neuropsychopharm, 2005; 15 (6): 641-646.

    Institut für Psychologie, Abteilung für Sozialpsychologie und Methodenlehre

  1. Detailinformationen: An Intensive Treatment Program of Interpersonal Psychotherapy Plus Pharmacotherapy for Depressed Inpatients: Acute and Long Term Results Schramm E, van Calker D, Dykierek P, Lieb K, Kech S, Zobel I, Leonhart R, Berger, M: An Intensive Treatment Program of Interpersonal Psychotherapy Plus Pharmacotherapy for Depressed Inpatients: Acute and Long Term Results The American Journal of Psychiatry, 2007; 164: 768-777.
  2. Detailinformationen: Time course of anger and other emotions in women with borderline personality disorder: A preliminary study. Jacob GA, Guenzler C, Zimmermann S, Scheel CN, Ruesch N, Leonhart R, Nerb J, Lieb K: Time course of anger and other emotions in women with borderline personality disorder: A preliminary study. J Behav Ther Exp Psy, 2008; 39: 391-402.

    Institut für Medizinische Biometrie und Medizinische Informatik, Abteilung Medizinische Biometrie und Statistik

  1. Detailinformationen: Predictors of dropout from inpatient dialectical behavior therapy among women with borderline personality disorder. Rüsch N, Schiel S, Corrigan PW, Leihener F, Jacob GA, Olschewski M, Lieb K, Bohus M: Predictors of dropout from inpatient dialectical behavior therapy among women with borderline personality disorder. J Behav Ther Exp Psy, 2008; 39 (4): 497-503. : http://dx.doi.org/10.1016/j.jbtep.2007.11.006
  2. Detailinformationen: Evaluation of the efficacy and effectiveness of a structured disorder tailored psychotherapy in ADHD in adults: study protocol of a randomized controlled multicentre trial. Philipsen A, Graf E, van Elst LT, Jans T, Warnke A, Hesslinger B, Ebert D, Gerlach M, Matthies S, Colla M, Jacob C, Sobanski E, Alm B, Rösler M, Ihorst G, Gross-Lesch S, Gentschow L, Kis B, Huss M, Lieb K, Schlander M, Berger M: Evaluation of the efficacy and effectiveness of a structured disorder tailored psychotherapy in ADHD in adults: study protocol of a randomized controlled multicentre trial. ADHD Attention Deficit and Hyperactivity Disorders, 2010; 2: 203-212. : http://dx.doi.org/10.1007/s12402-010-0046-7
  3. Detailinformationen: Pharmacological interventions for borderline personality disorder. Stoffers J, Völlm BA, Rücker G, Timmer A, Huband N, Lieb K: Pharmacological interventions for borderline personality disorder. Cochrane Db Syst Rev, 2010; 6 (online): CD005653. : http://dx.doi.org/10.1002/14651858.CD005653.pub2
  4. Detailinformationen: Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials. Lieb K, Völlm B, Rücker G, Timmer A, Stoffers JM: Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials. Brit J Psychiat, 2010; 196: 4-12. : http://dx.doi.org/10.1192/bjp.bp.108.062984

    Neurochirurgische Universitätsklinik, Abteilung Allgemeine Neurochirurgie mit Poliklinik

  1. Detailinformationen: Early life stress stimulates hippocampal reelin gene expression in a sex-specific manner: Evidence for corticosterone-mediated action Gross, CM, Flubacher, A, Tinnes, S, Heyer, A, Scheller, M, Herpfer, I, Berger, M, Frotscher, M, Lieb, K, Haas, CA: Early life stress stimulates hippocampal reelin gene expression in a sex-specific manner: Evidence for corticosterone-mediated action Hippocampus, 2011. : http://10.1002/hipo.20907 (download: http://onlinelibrary.wiley.com/doi/10.1002/hipo.20907/pdf) (in Druck)

    Institut für Anatomie und Zellbiologie, Abteilung Neuroanatomie

  1. Detailinformationen: Early life stress stimulates hippocampal reelin gene expression in a sex-specific manner: Evidence for corticosterone-mediated action. Gross C.M., Flubacher A., Tinnes S., Heyer A., Scheller M., Herpfer I., Berger M., Frotscher M., Lieb K., Haas C.A.: Early life stress stimulates hippocampal reelin gene expression in a sex-specific manner: Evidence for corticosterone-mediated action. Hippocampus, 2010. : http://dx.doi.org/10.1002/hipo.20907 (in Druck)